CVS’s Caremark division knowingly overcharged Medicare for prescription drugs and must pay nearly $290 million, a Pennsylvania federal judge has ordered in the case.
Whistleblower Sara Behnke, a former Aetna employee, filed the suit in 2014, alleging that CVS was up-billing Medicare for drugs handled by CVS Caremark, a pharmacy benefit manager, an entity that processes prescription drug claims. The federal government later agreed to intervene and pursue the lawsuit.
